Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

8.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

39.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.3K
Mismatch Repair01:20

Mismatch Repair

7.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

iRFP (near-infrared fluorescent protein) imaging of subcutaneous and deep tissue tumours in mice highlights differences between imaging platforms.

Cancer cell international·2021
Same author

Methods for Studying Interactions Between Atg8/LC3/GABARAP and LIR-Containing Proteins.

Methods in enzymology·2017
Same author

The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration.

Cell death & disease·2016
Same author

p53- and p73-independent activation of TIGAR expression in vivo.

Cell death & disease·2015
Same author

Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo.

Cell death and differentiation·2014
Same author

Suppression of acetate mutants in Coprinus : I. Identification of two isoaccepting tRNA suppressors of a missense mutation.

Current genetics·2013
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same journal

Correction: Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2.

Oncogene·2026
Same journal

Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Oncogene·2026
Same journal

Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitination.

Oncogene·2026
Same journal

DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment.

Oncogene·2026
Same journal

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

Oncogene·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K

Functional interplay between MDM2, p63/p73 and mutant p53.

M H Stindt1, P A J Muller1, R L Ludwig1

  • 1Cancer Research UK Beatson Institute, Glasgow, UK.

Oncogene
|November 25, 2014
PubMed
Summary
This summary is machine-generated.

Mutant p53 proteins interact with p63 and p73, influencing cancer progression. MDM2 modulates these interactions, affecting p63 and p73 activity differently based on p53 mutation type.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

357
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K

Related Experiment Videos

Last Updated: Apr 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

357
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Protein Interactions

Background:

  • Mutant p53 proteins often gain oncogenic functions, driving tumor progression.
  • Mutant p53 interacts with p53 family members p63 and p73, influencing their activities.
  • The role of MDM2 in modulating mutant p53 interactions with p63 and p73 is not fully understood.

Purpose of the Study:

  • To investigate the role of MDM2 in the interactions between mutant p53, p63, and p73.
  • To determine how MDM2 affects the binding affinities and functional outcomes of these protein complexes.

Main Methods:

  • Analysis of p53, p63, p73, and MDM2 protein interactions using various mutant p53 forms (e.g., R175H, R273H).
  • Assessment of MDM2's influence on p63 and p73 binding to mutant p53.
  • Evaluation of MDM2's impact on the functional consequences of these interactions, including inhibition of p63 and p73 activity.

Main Results:

  • MDM2 binding affinities vary: mutant p53 and p73 bind MDM2 well, while p63 binds weakly.
  • MDM2 differentially affects mutant p53 interactions: it inhibits p63 binding to p53R175H but enhances p73 binding to p53R273H.
  • MDM2 modulates p63 and p73 activity: it relieves p63 inhibition by p53R175H but enhances p73 inhibition by both p53R175H and p53R273H.

Conclusions:

  • MDM2 acts as a key regulator in mutant p53-p63/p73 complexes.
  • MDM2 can restore p63 activity by competing for p53R175H binding.
  • MDM2 enhances p73 inhibition by forming a trimeric complex with p53R273H and p73, suggesting distinct regulatory mechanisms.